{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:13:47Z","timestamp":1789517627504,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T00:00:00Z","timestamp":1541980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T00:00:00Z","timestamp":1541980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/13\/63\/30437"],"award-info":[{"award-number":["FS\/13\/63\/30437"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/13\/63\/30437"],"award-info":[{"award-number":["FS\/13\/63\/30437"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/13\/63\/30437"],"award-info":[{"award-number":["FS\/13\/63\/30437"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Citalopram, a selective serotonin reuptake inhibitor (SSRI), inhibits platelet function\n                    <jats:italic>in vitro<\/jats:italic>\n                    . We have previously shown that this action is independent of citalopram\u2019s ability to block serotonin uptake by the serotonin transporter and must therefore be mediated via distinct pharmacological mechanisms. We now report evidence for two novel and putative mechanisms of citalopram-induced platelet inhibition. Firstly, in platelets, citalopram blocked U46619-induced Rap1 activation and subsequent platelet aggregation, but failed to inhibit U46619-induced increases in cytosolic Ca\n                    <jats:sup>2+<\/jats:sup>\n                    . Similarly, in neutrophils, citalopram inhibited Rap1 activation and downstream functions but failed to block PAF-induced Ca\n                    <jats:sup>2+<\/jats:sup>\n                    mobilisation. In a cell-free system, citalopram also reduced CalDAG-GEFI-mediated nucleotide exchange on Rap1B. Secondly, the binding of anti-GPVI antibodies to resting platelets was inhibited by citalopram. Furthermore, citalopram-induced inhibition of GPVI-mediated platelet aggregation was instantaneous, reversible and displayed competitive characteristics, suggesting that these effects were not caused by a reduction in GPVI surface expression, but by simple competitive binding. In conclusion, we propose two novel, putative and distinct inhibitory mechanisms of action for citalopram: (1) inhibition of CalDAG-GEFI\/Rap1 signalling, and (2) competitive antagonism of GPVI in platelets. These findings may aid in the development of novel inhibitors of CalDAG-GEFI\/Rap1-dependent nucleotide exchange and novel GPVI antagonists.\n                  <\/jats:p>","DOI":"10.1038\/s41598-018-34389-5","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T06:21:33Z","timestamp":1541485293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Two novel, putative mechanisms of action for citalopram-induced platelet inhibition"],"prefix":"10.1038","volume":"8","author":[{"given":"Harvey G.","family":"Roweth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron A.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Moroi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3957-7849","authenticated-orcid":false,"given":"Arkadiusz M.","family":"Bonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Bergmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart O.","family":"Sage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4362-1133","authenticated-orcid":false,"given":"Gavin E.","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,12]]},"reference":[{"key":"34389_CR1","unstructured":"Bullard, I. Prescriptions Dispensed in the Community, England 2006 to 2016. (NHS Digital, 2017)."},{"key":"34389_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/354066a0","volume":"354","author":"RD Blakely","year":"1991","unstructured":"Blakely, R. D. et al. Cloning and expression of a functional serotonin transporter from rat brain. Nature 354, 66\u201370 (1991).","journal-title":"Nature"},{"key":"34389_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1126\/science.1948036","volume":"254","author":"BJ Hoffman","year":"1991","unstructured":"Hoffman, B. J., Mezey, E. & Brownstein, M. J. Cloning of a serotonin transporter affected by antidepressants. Science 254, 579\u2013580 (1991).","journal-title":"Science"},{"key":"34389_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0278-5846(82)80179-6","volume":"6","author":"J Hyttel","year":"1982","unstructured":"Hyttel, J. Citalopram pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog. Neuropsychopharmacol. Biol. Psychiatry 6, 277\u2013295 (1982).","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"34389_CR5","first-page":"5","volume":"65","author":"MJ Owens","year":"2004","unstructured":"Owens, M. J. Selectivity of antidepressants: From the monoamine hypothesis of depression to the SSRI revolution and beyond. J. Clin. Psychiatry 65, 5\u201310 (2004).","journal-title":"J Clin Psychiatry"},{"key":"34389_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejpn.2012.08.005","volume":"17","author":"C Goubau","year":"2013","unstructured":"Goubau, C., Buyse, G. M., Di Michele, M., Van Geet, C. & Freson, K. Regulated granule trafficking in platelets and neurons: A common molecular machinery. Eur. J. Paediatr. Neurol. 17, 117\u2013125 (2013).","journal-title":"Eur J Paediatr Neurol"},{"key":"34389_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1160\/TH03-05-0330","volume":"91","author":"E Maurer-Spurej","year":"2004","unstructured":"Maurer-Spurej, E., Pittendreigh, C. & Solomons, K. The influence of selective serotonin reuptake inhibitors on serotonin metabolism in human platelets. Thromb. Haemost. 91, 119\u2013128 (2004).","journal-title":"Thromb Haemost"},{"key":"34389_CR8","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1160\/TH17-04-0288","volume":"117","author":"I Lopez-vilchez","year":"2017","unstructured":"Lopez-Vilchez, I. et al. Escitalopram impairs thrombin-induced platelet response, cytoskeletal assembly and activation of associated signalling pathways. Thromb. Haemost. 117, 2312\u20132321 (2017).","journal-title":"Thromb Haemost"},{"key":"34389_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.thromres.2010.09.017","volume":"126","author":"YL Tseng","year":"2010","unstructured":"Tseng, Y. L. et al. A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation. Thromb. Res. 126, 517\u2013523 (2010).","journal-title":"Thromb Res"},{"key":"34389_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21348-3","volume":"8","author":"HG Roweth","year":"2018","unstructured":"Roweth, H. G. et al. Citalopram inhibits platelet function independently of SERT-mediated 5-HT transport. Sci. Rep. 8, 3494 (2018).","journal-title":"Sci Rep"},{"key":"34389_CR11","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1172\/JCI33374","volume":"118","author":"AMD Carneiro","year":"2008","unstructured":"Carneiro, A. M. D., Cook, E. H., Murphy, D. L. & Blakely, R. D. Interactions between integrin \u03b1IIb\u03b23 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J. Clin. Invest. 118, 1544\u20131552 (2008).","journal-title":"J Clin Invest"},{"key":"34389_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1160\/TH08-12-0810","volume":"102","author":"AM Galan","year":"2009","unstructured":"Galan, A. M. et al. Serotonergic mechanisms enhance platelet-mediated thrombogenicity. Thromb. Haemost. 102, 511\u2013519 (2009).","journal-title":"Thromb Haemost"},{"key":"34389_CR13","doi-asserted-by":"publisher","first-page":"30000","DOI":"10.1074\/jbc.M112.359125","volume":"287","author":"SM Jung","year":"2012","unstructured":"Jung, S. M. et al. Constitutive dimerization of glycoprotein VI (GPVI) in resting platelets is essential for binding to collagen and activation in flowing blood. J. Biol. Chem. 287, 30000\u201330013 (2012).","journal-title":"J Biol Chem"},{"key":"34389_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.thromres.2013.02.007","volume":"131","author":"YL Tseng","year":"2013","unstructured":"Tseng, Y. L., Chiang, M. L., Lane, H. Y., Su, K. P. & Lai, Y. C. Selective serotonin reuptake inhibitors reduce P2Y12 receptor-mediated amplification of platelet aggregation. Thromb. Res. 131, 325\u2013332 (2013).","journal-title":"Thromb Res"},{"key":"34389_CR15","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/nm1098","volume":"10","author":"JR Crittenden","year":"2004","unstructured":"Crittenden, J. R. et al. CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat. Med. 10, 982\u2013986 (2004).","journal-title":"Nat Med"},{"key":"34389_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00109-015-1346-3","volume":"94","author":"L Stefanini","year":"2016","unstructured":"Stefanini, L. & Bergmeier, W. RAP1-GTPase signaling and platelet function. J. Mol. Med. 94, 13\u201319 (2016).","journal-title":"J Mol Med"},{"key":"34389_CR17","first-page":"8521","volume":"293","author":"AA Cook","year":"2018","unstructured":"Cook, A. A. et al. Calcium-induced structural rearrangements release autoinhibition in the Rap-GEF, CalDAG-GEFI. J. Cell Biol. 293, 8521\u20138529 (2018).","journal-title":"J Cell Biol"},{"key":"34389_CR18","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1074\/jbc.M807117200","volume":"284","author":"HS Lee","year":"2009","unstructured":"Lee, H. S., Lim, C. J., Puzon-McLaughlin, W., Shattil, S. J. & Ginsberg, M. H. RIAM activates integrins by linking talin to Ras GTPase membrane-targeting sequences. J. Biol. Chem. 284, 5119\u20135122 (2009).","journal-title":"J Biol Chem"},{"key":"34389_CR19","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1126\/science.1163865","volume":"324","author":"M Moser","year":"2009","unstructured":"Moser, M., Legate, K. R., Zent, R. & Fassler, R. The tail of integrins, talin, and kindlins. Science 324, 895\u2013899 (2009).","journal-title":"Science"},{"key":"34389_CR20","doi-asserted-by":"crossref","unstructured":"M\u2019Rabet, L. et al. Activation of the small GTPase Rap1 in human neutrophils. Blood 92, 2133\u20132140 (1998).","DOI":"10.1182\/blood.V92.6.2133"},{"key":"34389_CR21","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1172\/JCI30575","volume":"117","author":"W Bergmeier","year":"2007","unstructured":"Bergmeier, W. et al. Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type III. J. Clin. Invest. 117, 1699\u20131707 (2007).","journal-title":"J Clin Invest"},{"key":"34389_CR22","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1097\/00000542-200306000-00009","volume":"98","author":"D Str\u00fcmper","year":"2003","unstructured":"Str\u00fcmper, D. et al. Effects of antidepressants on function and viability of human neutrophils. Anesthesiology 98, 1356\u20131362 (2003).","journal-title":"Anesthesiology"},{"key":"34389_CR23","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1182\/blood-2012-04-416594","volume":"120","author":"JM Burkhart","year":"2012","unstructured":"Burkhart, J. M. et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 120, e73\u2013e82 (2012).","journal-title":"Blood"},{"key":"34389_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21688370.2015.1052185","volume":"3","author":"MD Filippi","year":"2015","unstructured":"Filippi, M. D. Leukocyte transcellular diapedesis: Rap1b is in control. Tissue Barriers 3, 1\u20138 (2015).","journal-title":"Tissue Barriers"},{"key":"34389_CR25","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1084\/jem.20131706","volume":"211","author":"S Kumar","year":"2014","unstructured":"Kumar, S. et al. The small GTPase Rap1b negatively regulates neutrophil chemotaxis and transcellular diapedesis by inhibiting Akt activation. J. Exp. Med. 211, 1741\u20131758 (2014).","journal-title":"J Exp Med"},{"key":"34389_CR26","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S0960-9822(00)00641-2","volume":"10","author":"E Caron","year":"2000","unstructured":"Caron, E., Self, A. J. & Hall, A. The GTPase Rap1 controls functional activation of macrophage integrin \u03b1M\u03b22 by LPS and other inflammatory mediators. Curr. Biol. 10, 974\u2013978 (2000).","journal-title":"Curr Biol"},{"key":"34389_CR27","doi-asserted-by":"publisher","first-page":"13995","DOI":"10.1074\/jbc.M010174200","volume":"276","author":"VP Yakubenko","year":"2001","unstructured":"Yakubenko, V. P. et al. Identification of the Binding Site for Fibrinogen Recognition Peptide \u03b3383-395 within the \u03b1MI-Domain of Integrin \u03b1M\u03b22. J. Biol. Chem. 276, 13995\u201314003 (2001).","journal-title":"J Biol Chem"},{"key":"34389_CR28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/jth.13613","volume":"15","author":"NS Poulter","year":"2017","unstructured":"Poulter, N. S., Pollitt, A. Y., Owen, D. M., Gardiner, E. E. & Andrews, R. K. Clustering of glycoprotein VI (GPVI) dimers upon adhesion to collagen as a mechanism to regulate GPVI signaling in platelets. J. Thromb. Haemost. 15, 549\u2013564 (2017).","journal-title":"J Thromb Haemost"},{"key":"34389_CR29","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0022-3565(24)36684-4","volume":"281","author":"BT Kinsella","year":"1997","unstructured":"Kinsella, B. T., O\u2019Mahony, D. J. & Fitzgerald, G. A. The human thromboxane A2 receptor\u00a0\u03b1 isoform (TP\u03b1) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2\u03b1. J. Pharmacol. Exp. Ther. 281, 957\u201364 (1997).","journal-title":"J Pharmacol Exp Ther."},{"key":"34389_CR30","doi-asserted-by":"publisher","first-page":"29108","DOI":"10.1074\/jbc.274.41.29108","volume":"274","author":"BZS Paul","year":"1999","unstructured":"Paul, B. Z. S., Jin, J. & Kunapuli, S. P. Molecular Mechanism of Thromboxane A2-induced Platelet Aggregation. J. Biol. Chem. 274, 29108\u201329114 (1999).","journal-title":"J Biol Chem"},{"key":"34389_CR31","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/oxfordjournals.jbchem.a003164","volume":"131","author":"Z Honda","year":"2002","unstructured":"Honda, Z., Ishii, S. & Shimizu, T. Platelet-activating factor receptor. J. Biochem. 131, 773\u2013779 (2002).","journal-title":"J Biochem"},{"key":"34389_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcvm.2017.00048","volume":"4","author":"N Herr","year":"2017","unstructured":"Herr, N., Bode, C. & Duerschmied, D. The effects of serotonin in immune cells. Front. Cardiovasc. Med. 4, 1\u201311 (2017).","journal-title":"Front Cardiovasc Med"},{"key":"34389_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1476-5381.1985.tb12941.x","volume":"84","author":"JW Black","year":"1985","unstructured":"Black, J. W., Leff, P., Shankley, N. P. & Wood, J. An operational model of pharmacological agonism: the effect of E\/[A] curve shape on agonist dissociation constant estimation. Br. J. Pharmacol. 84, 561\u2013571 (1985).","journal-title":"Br J Pharmacol"},{"key":"34389_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1042\/bj20020335","volume":"368","author":"DC Snell","year":"2002","unstructured":"Snell, D. C. et al. Differential effects of reduced glycoprotein VI levels on activation of murine platelets by glycoprotein VI ligands. Biochem. J. 368, 293\u2013300 (2002).","journal-title":"Biochem J"},{"key":"34389_CR35","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1038\/npp.2012.35","volume":"37","author":"A Bonnin","year":"2012","unstructured":"Bonnin, A., Zhang, L., Blakely, R. D. & Levitt, P. The SSRI citalopram affects fetal thalamic axon responsiveness to netrin-1 in vitro independently of SERT antagonism. Neuropsychopharmacology 37, 1879\u20131884 (2012).","journal-title":"Neuropsychopharmacology"},{"key":"34389_CR36","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0006-3223(01)01145-3","volume":"50","author":"MJ Owens","year":"2001","unstructured":"Owens, M. J., Knight, D. L. & Nemeroff, C. B. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol. Psychiatry 50, 345\u2013350 (2001).","journal-title":"Biol Psychiatry"},{"key":"34389_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.323.7303.1","volume":"323","author":"C van Walraven","year":"2001","unstructured":"van Walraven, C., Mamdani, M. M., Wells, P. S. & Williams, J. I. Inhibition of serotonin reuptake by antidepressants and retrospective cohort study. Br. Med. J. 323, 1\u20136 (2001).","journal-title":"Br Med J"},{"key":"34389_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/archinte.163.1.59","volume":"163","author":"SO Dalton","year":"2003","unstructured":"Dalton, S. O. et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding. Arch. Intern. Med. 163, 59\u201364 (2003).","journal-title":"Arch Intern Med"},{"key":"34389_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2125.2008.03154.x","volume":"66","author":"L Opatrny","year":"2008","unstructured":"Opatrny, L., Delaney, J. A. C. & Suissa, S. Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: A new look. Br. J. Clin. Pharmacol. 66, 76\u201381 (2008).","journal-title":"Br J Clin Pharmacol"},{"key":"34389_CR40","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.cgh.2009.08.019","volume":"7","author":"M Dall","year":"2009","unstructured":"Dall, M. et al. An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding. Clin. Gastroenterol. Hepatol. 7, 1314\u20131321 (2009).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"34389_CR41","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1212\/WNL.0b013e318271f848","volume":"79","author":"DG Hackam","year":"2012","unstructured":"Hackam, D. G. & Mrkobrada, M. Selective serotonin reuptake inhibitors and brain hemorrhage. Neurology 79, 1862\u20131865 (2012).","journal-title":"Neurology"},{"key":"34389_CR42","first-page":"65","volume":"272","author":"GE Jarvis","year":"2004","unstructured":"Jarvis, G. E. Platelet aggregation: turbidimetric measurements. Methods Mol. Biol. 272, 65\u201376 (2004).","journal-title":"Methods Mol Biol"},{"key":"34389_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/sj.bjp.0703046","volume":"129","author":"GE Jarvis","year":"2000","unstructured":"Jarvis, G. E., Humphries, R. G., Robertson, M. J. & Leff, P. ADP can induce aggregation of human platelets via both P2Y1 and P2T receptors. Br. J. Pharmacol. 129, 275\u2013282 (2000).","journal-title":"Br J Pharmacol"},{"key":"34389_CR44","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","volume":"260","author":"G Grynkiewicz","year":"1985","unstructured":"Grynkiewicz, G., Poenie, M. & Tsien, R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440\u20133450 (1985).","journal-title":"J Biol Chem"},{"key":"34389_CR45","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1182\/blood-2015-11-683102","volume":"128","author":"ML Lozano","year":"2016","unstructured":"Lozano, M. L. et al. Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction. Blood 128, 1282\u20131289 (2016).","journal-title":"Blood"},{"key":"34389_CR46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bbrc.2016.04.100","volume":"474","author":"J Ren","year":"2016","unstructured":"Ren, J., Cook, A. A., Bergmeier, W. & Sondek, J. A negative-feedback loop regulating ERK1\/2 activation and mediated by RasGPR2 phosphorylation. Biochem. Biophys. Res. Commun. 474, 193\u2013198 (2016).","journal-title":"Biochem Biophys Res Commun"},{"key":"34389_CR47","first-page":"444","volume":"216","author":"P Bellavite","year":"1994","unstructured":"Bellavite, P. et al. A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal. Chem. 216, 444\u2013450 (1994).","journal-title":"Anal Chem"},{"key":"34389_CR48","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/j.1538-7836.2009.03496.x","volume":"7","author":"SM Jung","year":"2009","unstructured":"Jung, S. M., Tsuji, K. & Moroi, M. Glycoprotein (GP) VI dimer as a major collagen-binding site of native platelets: direct evidence obtained with dimeric GPVI-specific Fabs. J. Thromb. Haemost. 7, 1347\u20131355 (2009).","journal-title":"J Thromb Haemost"},{"key":"34389_CR49","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1074\/jbc.M109714200","volume":"277","author":"H Chen","year":"2002","unstructured":"Chen, H., Locke, D., Liu, Y., Liu, C. & Kahn, M. L. The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion. J. Biol. Chem. 277, 3011\u20133019 (2002).","journal-title":"J Biol Chem"},{"key":"34389_CR50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1152\/ajpcell.1978.235.3.C97","volume":"235","author":"A DeLean","year":"1978","unstructured":"DeLean, A., Munson, P. J. & Rodbard, D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 235, 97\u2013102 (1978).","journal-title":"Am J Physiol"},{"key":"34389_CR51","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1172\/JCI77993","volume":"125","author":"L Stefanini","year":"2015","unstructured":"Stefanini, L. et al. RASA3 is a critical inhibitor of RAP1-dependent platelet activation. J. Clin. Invest. 125, 1419\u20131432 (2015).","journal-title":"J Clin Invest"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34389-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34389-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34389-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:58:48Z","timestamp":1775260728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34389-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,12]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["34389"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-34389-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,12]]},"assertion":[{"value":"10 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16677"}}